Riconoscimento tempestivo

Speaker:
Andrea Fagiolini
Professore Ordinario di Psichiatria Dipartimento di Medicina Molecolare e dello Sviluppo, Policlinico Le Scotte Siena

Quali benefici si riscontrano nei pazienti, quando vi è stato un riconoscimento precoce di una risposta inadeguata?

Speakers:
Siegfried Kasper
Professor and Chair, Department of Psychiatry and Psychotherapy, Medical University of Vienna
Allan Young
Professor of Psychology & Director of the Centre for Affective Disorders King's College, London

Le percentuali di remissione possono ridursi fino al 14% e al 13% rispettivamente per la terza e quarta terapia antidepressiva.^*2

REFERENCES

1. Al-Harbi K et al. Patient Prefer Adherence 2012; 6: 369-388. 
2. Rush AJ et al. Am J Psychiatry 2006; 163(11): 1905‒1917. 
3. World Health Organisation. Depression and Other Common Mental Health Disorders: Global Health Estimates, 2017. Last accessed September 2018. 
4. World Federation for Mental Health. DEPRESSION: A Global Crisis, 2012. Last accessed September 2018.
5. World Health Organisation. Depression Fact Sheet, 2018.  Last accessed September 2018.
6. Diagnostics and statistical manual of mental disorders. Fifth Edition. 2013.
7. APA. Practice guidelines for the treatment of patients with major depressive disorder. Third edition. 2010.
8. Lepine JP, Briley M. Neuropsychiatr Dis Treat 2011; 7(Suppl 1): 3-7. 
9. Ferrari AJ et al. PLoS Med 2013;10(11): e1001547. 
10. Sobocki P et al. J Ment Health Policy Econ 2006; 9(2): 87-98. 
11. Anacker C. Biol Psychiatry 2018; 83(1): e5-e7. 
12. Leuchter AF et al. Dialogues Clin Neurosci 2009; 11(4): 435–446. 
13. Munoz C. Medicographia 2014; 36(4): 501-507. 
14. Machado-Vieira R et al. Pharmaceuticals 2010; 3(1): 19-41. 
15. Machado-Vieira R et al. J Clin Psychiatry 2008; 69(6): 946-958. 
16. Oluboka O et al. Int J Neuropsychopharmacol 2017; 21(2): 128-144. 
17. Gormley N et al. J Affect Disord 1999; 54(1-2): 49-54. 
18. Okuda A et al. Psychiatry Clin Neurosci 2010; 64(3): 268-273. 
19. Bukh J et al. J Affect Disord 2013; 145(1): 42-48. 
20. Reid I et al. Prescriber 2014; 25(4): 16-20. 
21. Van Krugten F et al. PLOS One 2017; 12(2): e0171659.

EM-160601